The age of cancer
10.1038/35041694
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

DePinho, R. A. (2000). The age of cancer. Nature, 408(6809), 248–254.

Authors 1
  1. Ronald A. DePinho (first)
References 95 Referenced 769
  1. American Cancer Society. Cancer Facts and Figures 2000 1–7 (American Cancer Society, Atlanta, 2000).
  2. Bishop, J. M. Molecular themes in oncogenesis. Cell 64, 235–248 (1991). (10.1016/0092-8674(91)90636-D) / Cell by JM Bishop (1991)
  3. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976). (10.1126/science.959840) / Science by PC Nowell (1976)
  4. Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525–532 (1988). (10.1056/NEJM198809013190901) / N. Engl. J. Med. by B Vogelstein (1988)
  5. Balaban, G. B., Herlyn, M., Clark, W. H. Jr & Nowell, P. C. Karyotypic evolution in human malignant melanoma. Cancer Genet. Cytogenet. 19, 113–122 ( 1986). (10.1016/0165-4608(86)90378-X) / Cancer Genet. Cytogenet. by GB Balaban (1986)
  6. Naylor, S. L., Johnson, B. E., Minna, J. D. & Sakaguchi, A. Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer . Nature 329, 451–454 (1987). (10.1038/329451a0) / Nature by SL Naylor (1987)
  7. James, C. D. et al. Clonal genomic alterations in glioma malignancy stages. Cancer Res. 48, 5546–5551 (1988). / Cancer Res. by CD James (1988)
  8. Rabinovitch, P. S., Reid, B. J., Haggitt, R. C., Norwood, T. H. & Rubin, C. E. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab. Invest. 60, 65–71 ( 1988). / Lab. Invest. by PS Rabinovitch (1988)
  9. Harman, D. Aging: a theory based on free-radical and radiation chemistry. J. Gerontol. 6, 298–300 (1956). (10.1093/geronj/11.3.298) / J. Gerontol. by D Harman (1956)
  10. Ames, B. N., Shigenaga, M. K. & Hagen, T. M. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl Acad. Sci. USA 90, 7915–7922 (1993). (10.1073/pnas.90.17.7915) / Proc. Natl Acad. Sci. USA by BN Ames (1993)
  11. Minnick, D. T. & Kunkel, T. A. DNA synthesis errors, mutators and cancer. Cancer Surv. 28, 3–20 (1996). / Cancer Surv. by DT Minnick (1996)
  12. Oller, A. R., Rastogi, P., Morgenthaler, S. & Thilly, W. G. A statistical model to estimate variance in long term-low dose mutation assays: testing of the model in a human lymphoblastoid mutation assay. Mutat. Res. 216, 149–161 (1989). (10.1016/0165-1161(89)90001-0) / Mutat. Res. by AR Oller (1989)
  13. Jackson, A. L. & Loeb, L. A. The mutation rate and cancer. Genetics 148, 1483– 1490 (1998). (10.1093/genetics/148.4.1483) / Genetics by AL Jackson (1998)
  14. Armitage, P. & Doll, R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8, 1–12 (1954). (10.1038/bjc.1954.1) / Br. J. Cancer by P Armitage (1954)
  15. Renan, M. J. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol. Carcinog. 7, 139– 146 (1993). (10.1002/mc.2940070303) / Mol. Carcinog. by MJ Renan (1993)
  16. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 ( 2000). (10.1016/S0092-8674(00)81683-9) / Cell by D Hanahan (2000)
  17. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075–3079 (1991). / Cancer Res. by LA Loeb (1991)
  18. Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159 –170 (1996). (10.1016/S0092-8674(00)81333-1) / Cell by KW Kinzler (1996)
  19. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386, 623–627 ( 1997). (10.1038/386623a0) / Nature by C Lengauer (1997)
  20. Gray, J. W. & Collins, C. Genome changes and gene expression in human solid tumors. Carcinogenesis 21, 443–452 (2000). (10.1093/carcin/21.3.443) / Carcinogenesis by JW Gray (2000)
  21. Weinberg, R. The cat and mouse games that genes, viruses, and cells play. Cell 88, 573–575 ( 1997). (10.1016/S0092-8674(00)81897-8) / Cell by R Weinberg (1997)
  22. Turker, M. S. Estimation of mutation frequencies in normal mammalian cells and the development of cancer. Semin. Cancer Biol. 8, 407– 419 (1998). (10.1006/scbi.1998.0112) / Semin. Cancer Biol. by MS Turker (1998)
  23. Dolle, M. E. et al. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nature Genet. 17, 431–434 (1997). (10.1038/ng1297-431) / Nature Genet. by ME Dolle (1997)
  24. Dolle, M. E., Snyder, W. K., Gossen, J. A., Lohman, P. H. & Vijg, J. Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine. Proc. Natl Acad. Sci. USA 97, 8403–8408 (2000). (10.1073/pnas.97.15.8403) / Proc. Natl Acad. Sci. USA by ME Dolle (2000)
  25. Vijg, J. & Dolle, M. E. T. in Handbook of the Biology of Ageing 5th edn (eds Masoro, E. J. & Austad, S. N.) (Academic, in the press).
  26. Curtis, H. & Crowley, C. Chromosome aberrations in liver cells in relation to the somatic mutation theory of aging. Radiat. Res. 19, 337–344 ( 1963). (10.2307/3571455) / Radiat. Res. by H Curtis (1963)
  27. Ly, D. H., Lockhart, D. J., Lerner, R. A. & Schultz, P. G. Mitotic misregulation and human aging. Science 287, 2486–2492 (2000). (10.1126/science.287.5462.2486) / Science by DH Ly (2000)
  28. Ramsey, M. J. et al. The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat. Res. 338, 95–106 ( 1995). (10.1016/0921-8734(95)00015-X) / Mutat. Res. by MJ Ramsey (1995)
  29. Jacobs, P., Brunton, M., Brown, W., Doll, R. & Goldstein, H. Change of human chromosome count distributions with age: evidence for a sex difference. Nature 197, 1080–1081 (1963). (10.1038/1971080a0) / Nature by P Jacobs (1963)
  30. Tucker, J. D., Spruill, M. D., Ramsey, M. J., Director, A. D. & Nath, J. Frequency of spontaneous chromosome aberrations in mice: effects of age. Mutat. Res. 425 , 135–141 (1999). (10.1016/S0027-5107(99)00036-6) / Mutat. Res. by JD Tucker (1999)
  31. Moriwaki, S., Ray, S., Tarone, R. E., Kraemer, K. H. & Grossman, L. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat. Res. 364, 117– 123 (1996). (10.1016/0921-8777(96)00029-8) / Mutat. Res. by S Moriwaki (1996)
  32. Goukassian, D. et al. Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J. 14, 1325 –1334 (2000). (10.1096/fasebj.14.10.1325) / FASEB J. by D Goukassian (2000)
  33. Liu, S. C., Parsons, C. S. & Hanawalt, P. C. DNA repair response in human epidermal keratinocytes from donors of different age. J. Invest. Dermatol. 79, 330–335 (1982). (10.1111/1523-1747.ep12500087) / J. Invest. Dermatol. by SC Liu (1982)
  34. Kolodner, R. D. et al. Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 59, 5068–5074 (1999). / Cancer Res. by RD Kolodner (1999)
  35. Baylin, S. B. & Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168–174 (2000). (10.1016/S0168-9525(99)01971-X) / Trends Genet. by SB Baylin (2000)
  36. Jones, P. A. & Laird, P. W. Cancer epigenetics comes of age . Nature Genet. 21, 163– 167 (1999). (10.1038/5947) / Nature Genet. by PA Jones (1999)
  37. Issa, J. P. et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7, 536–540 (1994). (10.1038/ng0894-536) / Nature Genet. by JP Issa (1994)
  38. Issa, J. P. Aging, DNA methylation and cancer. Crit. Rev. Oncol. Hematol. 32, 31–43 (1999). (10.1016/S1040-8428(99)00019-0) / Crit. Rev. Oncol. Hematol. by JP Issa (1999)
  39. Cormier, R. T. & Dove, W. F. Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele. Cancer Res. 60, 3965–3970 ( 2000). / Cancer Res. by RT Cormier (2000)
  40. Laird, P. W. et al. Suppression of intestinal neoplasia by DNA hypomethylation . Cell 81, 197–205 (1995). (10.1016/0092-8674(95)90329-1) / Cell by PW Laird (1995)
  41. Rhee, I. et al. CpG methylation is maintained in human cancer cells lacking DNMT1 . Nature 404, 1003–1007 (2000). (10.1038/35010000) / Nature by I Rhee (2000)
  42. DePinho, R. A. & Sherr, C. J. Cellular senescence: mitotic clock or culture shock? Cell 102, 407–410 (2000). (10.1016/S0092-8674(00)00046-5) / Cell by RA DePinho (2000)
  43. Atkin, N. B. Solid tumor cytogenetics. Progress since 1979. Cancer Genet. Cytogenet. 40, 3–12 (1989 ). (10.1016/0165-4608(89)90140-4) / Cancer Genet. Cytogenet. by NB Atkin (1989)
  44. Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000). (10.1038/35020592) / Nature by SE Artandi (2000)
  45. Greider, C. Telomerase activity, cell proliferation, and cancer. Proc. Natl Acad. Sci. USA 95, 90 (1998). (10.1073/pnas.95.1.90) / Proc. Natl Acad. Sci. USA by C Greider (1998)
  46. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts . Nature 345, 458–460 (1990). (10.1038/345458a0) / Nature by CB Harley (1990)
  47. Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866– 868 (1990). (10.1038/346866a0) / Nature by ND Hastie (1990)
  48. Allsopp, R. C. et al. Telomere length predicts replicative capacity of human fibroblasts . Proc. Natl Acad. Sci. USA 89, 10114– 10118 (1992). (10.1073/pnas.89.21.10114) / Proc. Natl Acad. Sci. USA by RC Allsopp (1992)
  49. Chadeneau, C., Hay, K., Hirte, H. W., Gallinger, S. & Bacchetti, S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55, 2533–2536 (1995). / Cancer Res. by C Chadeneau (1995)
  50. Kipling, D. & Cooke, H. J. Hypervariable ultra-long telomeres in mice. Nature 347, 400– 402 (1990). (10.1038/347400a0) / Nature by D Kipling (1990)
  51. Prowse, K. R. & Greider, C. W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl Acad. Sci. USA 92, 4818–4822 (1995). (10.1073/pnas.92.11.4818) / Proc. Natl Acad. Sci. USA by KR Prowse (1995)
  52. Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E. & de, L. T. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16, 3765–3772 (1996). (10.1128/MCB.16.7.3765) / Mol. Cell. Biol. by D Broccoli (1996)
  53. Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B. & DePinho, R. A. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723–1730 ( 1998). (10.1038/sj.onc.1201933) / Oncogene by RA Greenberg (1998)
  54. Martin-Rivera, L., Herrera, E., Albar, J. & Blasco, M. A. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl Acad. Sci. USA 95, 10471– 10476 (1998). (10.1073/pnas.95.18.10471) / Proc. Natl Acad. Sci. USA by L Martin-Rivera (1998)
  55. Counter, C. M. et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921–1929 ( 1992). (10.1002/j.1460-2075.1992.tb05245.x) / EMBO J. by CM Counter (1992)
  56. McClintock, B. The stability of broken ends of chromosomes in Zea mays. Genetics 26, 234–282 ( 1941). (10.1093/genetics/26.2.234) / Genetics by B McClintock (1941)
  57. Nishizaki, T. et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 19, 267–272 (1997). (10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V) / Genes Chromosomes Cancer by T Nishizaki (1997)
  58. Buerger, H. et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J. Pathol. 187, 396–402 ( 1999). (10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L) / J. Pathol. by H Buerger (1999)
  59. Al-Mulla, F., Keith, W. N., Pickford, I. R., Going, J. J. & Birnie, G. D. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases . Genes Chromosomes Cancer 24, 306– 314 (1999). (10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5) / Genes Chromosomes Cancer by F Al-Mulla (1999)
  60. Tang, R., Cheng, A. J., Wang, J. Y. & Wang, T. C. Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. Cancer Res. 58, 4052–4054 (1998). / Cancer Res. by R Tang (1998)
  61. Lee, H. W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569– 574 (1998). (10.1038/33345) / Nature by HW Lee (1998)
  62. Rudolph, K. L. et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701–712 (1999). (10.1016/S0092-8674(00)80580-2) / Cell by KL Rudolph (1999)
  63. de Lange, T. Activation of telomerase in a human tumor. Proc. Natl Acad. Sci. USA 91, 2882–2885 ( 1994). (10.1073/pnas.91.8.2882) / Proc. Natl Acad. Sci. USA by T de Lange (1994)
  64. Foley, K. P. & Eisenman, R. N. Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. Biochim. Biophys. Acta 1423, M37–M47 (1999). / Biochim. Biophys. Acta by KP Foley (1999)
  65. Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N. & DePinho, R. A. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 287, 1253–1258 (2000). (10.1126/science.287.5456.1253) / Science by KL Rudolph (2000)
  66. Kitada, T., Seki, S., Kawakita, N., Kuroki, T. & Monna, T. Telomere shortening in chronic liver diseases. Biochem. Biophys. Res. Commun. 211, 33– 39 (1995). (10.1006/bbrc.1995.1774) / Biochem. Biophys. Res. Commun. by T Kitada (1995)
  67. Miura, N. et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet. Cytogenet. 93, 56–62 (1997). (10.1016/S0165-4608(96)00329-9) / Cancer Genet. Cytogenet. by N Miura (1997)
  68. Urabe, Y. et al. Telomere length in human liver diseases. Liver 16, 293–297 (1996). (10.1111/j.1600-0676.1996.tb00748.x) / Liver by Y Urabe (1996)
  69. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995). (10.1016/0092-8674(95)90385-2) / Cell by RA Weinberg (1995)
  70. Debbas, M. & White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7, 546–554 (1993). (10.1101/gad.7.4.546) / Genes Dev. by M Debbas (1993)
  71. Symonds, H. et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703–711 (1994). (10.1016/0092-8674(94)90534-7) / Cell by H Symonds (1994)
  72. Morgenbesser, S. D., Williams, B. O., Jacks, T. & DePinho, R. A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371, 72–74 (1994). (10.1038/371072a0) / Nature by SD Morgenbesser (1994)
  73. Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011– 2015 (1994). (10.1126/science.7605428) / Science by NW Kim (1994)
  74. Blasco, M. A., Rizen, M., Greider, C. W. & Hanahan, D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genet. 12, 200– 204 (1996). (10.1038/ng0296-200) / Nature Genet. by MA Blasco (1996)
  75. Greenberg, R. A. et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a(Δ2/3) cancer-prone mouse. Cell 97, 515–525 (1999). (10.1016/S0092-8674(00)80761-8) / Cell by RA Greenberg (1999)
  76. Hahn, W. C. et al. Creation of human tumour cells with defined genetic elements . Nature 400, 464–468 (1999). (10.1038/22780) / Nature by WC Hahn (1999)
  77. Chin, L. & DePinho, R. A. Flipping the oncogene switch: illumination of tumor maintenance and regression. Trends Genet. 16, 147–150 ( 2000). (10.1016/S0168-9525(99)01968-X) / Trends Genet. by L Chin (2000)
  78. Chin, L. et al. Essential role for oncogenic RAS in tumour maintenance. Nature 400, 468–472 ( 1999). (10.1038/22788) / Nature by L Chin (1999)
  79. Pelengaris, S., Littlewood, T., Khan, M., Elia, G. & Evan, G. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3 , 565–577 (1999). (10.1016/S1097-2765(00)80350-0) / Mol. Cell by S Pelengaris (1999)
  80. Gelman, R., Watson, A., Bronson, R. & Yunis, E. Murine chromosomal regions correlated with longevity. Genetics 118, 693–704 (1988). (10.1093/genetics/118.4.693) / Genetics by R Gelman (1988)
  81. Cunha, G. & Hom, Y. Role of mesenchymal-epithelial interactions in mammary gland development. J. Mamm. Gland Biol. Neoplasia 1, 21–35 (1996). (10.1007/BF02096300) / J. Mamm. Gland Biol. Neoplasia by G Cunha (1996)
  82. Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999). / Cancer Res. by AF Olumi (1999)
  83. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995). (10.1073/pnas.92.20.9363) / Proc. Natl Acad. Sci. USA by GP Dimri (1995)
  84. Shelton, D. N., Chang, E., Whittier, P. S., Choi, D. & Funk, W. D. Microarray analysis of replicative senescence. Curr. Biol. 9, 939– 945 (1999). (10.1016/S0960-9822(99)80420-5) / Curr. Biol. by DN Shelton (1999)
  85. Campisi, J. Aging and cancer: the double-edged sword of replicative senescence. J. Am. Geriatr. Soc. 45, 482–488 (1997). (10.1111/j.1532-5415.1997.tb05175.x) / J. Am. Geriatr. Soc. by J Campisi (1997)
  86. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 ( 1997). (10.1016/S0092-8674(00)81902-9) / Cell by M Serrano (1997)
  87. Di Leonardo, A., Linke, S. P., Clarkin, K. & Wahl, G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994). (10.1101/gad.8.21.2540) / Genes Dev. by A Di Leonardo (1994)
  88. Coussens, L. M. et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382–1397 (1999). (10.1101/gad.13.11.1382) / Genes Dev. by LM Coussens (1999)
  89. Bergers, G. et al. Matrix metalloprotein-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol. 2, 737 –744 (2000). (10.1038/35036374) / Nature Cell Biol. by G Bergers (2000)
  90. Coussens, L., Tinkle, C., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell (in the press). (10.1016/S0092-8674(00)00139-2)
  91. Millis, A. J., Hoyle, M., McCue, H. M. & Martini, H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp. Cell Res. 201, 373 –379 (1992). (10.1016/0014-4827(92)90286-H) / Exp. Cell Res. by AJ Millis (1992)
  92. Sternlicht, M. D. et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137– 146 (1999). (10.1016/S0092-8674(00)81009-0) / Cell by MD Sternlicht (1999)
  93. Robertson, K. D. & Jones, P. A. DNA methylation: past, present and future directions. Carcinogenesis 21, 461–467 (2000). (10.1093/carcin/21.3.461) / Carcinogenesis by KD Robertson (2000)
  94. Piantanelli, L. Cancer and aging: from the kinetics of biological parameters to the kinetics of cancer incidence and mortality. Ann. NY Acad. Sci. 521, 99–109 (1988). (10.1111/j.1749-6632.1988.tb35268.x) / Ann. NY Acad. Sci. by L Piantanelli (1988)
  95. Schwartz, R. A. Skin Cancer: Recognition and Management (Springer, New York, 1988). (10.1007/978-1-4612-3790-7)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:33 a.m.)
Deposited 2 years, 3 months ago (May 16, 2023, 10:13 p.m.)
Indexed 1 month, 1 week ago (July 26, 2025, 5:21 a.m.)
Issued 24 years, 10 months ago (Nov. 1, 2000)
Published 24 years, 10 months ago (Nov. 1, 2000)
Published Print 24 years, 10 months ago (Nov. 1, 2000)
Funders 0

None

@article{DePinho_2000, title={The age of cancer}, volume={408}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/35041694}, DOI={10.1038/35041694}, number={6809}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={DePinho, Ronald A.}, year={2000}, month=nov, pages={248–254} }